Juntendo University
Also known as: Chieko Hamada | Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine | Department of Respiratory medicine, Juntendo University | Junten Bio Co., Ltd. | Juntendo University | Juntendo University Advanced Research Institute for Health Science | Juntendo University Graduate School of Medicine | Juntendo University Hospital | Juntendo University School of Medicine | Juntendo University School of Medicine, Dept. of Endocrinology and Metabolism | Juntenndo University Hospital | Katsumi Miyauchi | Professor of Medicine, Department of Cardiovascular Medicine, Juntendo University School of Medicine | Professor of Medicine, Department of Nephrology, Juntendo University Graduate School of Medicine
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2004Last known activity
Sep 10, 2022
Timeline
1940s
- Jan 1, 1946
Juntendo University— Founded
Drugs by trial phase (30 distinct, 15 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Atherosclerosis
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Duodenal Ulcer
- Esophagitis
- Esophagitis, Peptic
- Gastroesophageal Reflux
- Hypercholesterolemia
- Hypertension
- Lung Diseases
- Lung Diseases, Obstructive
- Myocardial Ischemia
- Pancreatic Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Stomach Ulcer
- Ulcer
Recent trials (29)
- NCT05392764Lead sponsorPhase 3Sep 10, 2022
- NCT05392764Overall official - principal investigatorPhase 3Sep 10, 2022
- NCT05392764Reponsible party - principal investigatorPhase 3Sep 10, 2022
- NCT05258279Lead sponsorPhase 2Jul 31, 2022
- NCT05258279Overall official - principal investigatorPhase 2Jul 31, 2022
- NCT05258279Reponsible party - principal investigatorPhase 2Jul 31, 2022
- NCT04950842Lead sponsorPhase 1/Phase 2Dec 15, 2020
- NCT04950842CollaboratorPhase 1/Phase 2Dec 15, 2020
- NCT04950842Study chairPhase 1/Phase 2Dec 15, 2020
- NCT04950842Reponsible party - principal investigatorPhase 1/Phase 2Dec 15, 2020
- NCT03553563Study chairPhase 3Jul 24, 2018
- NCT02669732Overall official - principal investigatorN/AJan 1, 2016
- NCT02324283Overall official - principal investigatorN/AOct 1, 2012
- NCT02324283Reponsible party - principal investigatorN/AOct 1, 2012
- NCT02324283Lead sponsorN/AOct 1, 2012
Details
- Founded
- Tokyo, JP Jan 1, 1946
- Last known activity
- Sep 10, 2022